Form 4: Ascendis Pharma A/S Director Buys Shares
Insider Transaction (Form 4)
Jean Jacques Bienaime, a Director of Ascendis Pharma A/S, purchased 2,000 shares of common stock on August 14, 2026.
Summary
- Open-market purchase: acquired 1,100 Ordinary Shares at $245.85 ($270,435) on August 14, 2026; holds 2,000 after (Direct).
- Open-market purchase: acquired 900 Ordinary Shares at $246.91 ($222,219) on August 14, 2026; holds 2,900 after (Direct).
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $492,654, committing personal capital to the stock.
Insider Transactions
Jean Jacques Bienaime — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Open-market purchase | Ordinary Shares | 1,100 | $246 | $270.4K | 2,000 |
| 2026-08-14 | Open-market purchase | Ordinary Shares | 900 | $247 | $222.2K | 2,900 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Open-market purchase (1,100 shares) |
| 2026-08-14 | Open-market purchase (900 shares) |
Keywords
insider transaction, Form 4, ASND, Ascendis Pharma A/S, bullish, Jean Jacques Bienaime
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.